www.fdanews.com/articles/73729-provid-announces-discovery-collaboration-with-immune-control
PROVID ANNOUNCES DISCOVERY COLLABORATION WITH IMMUNE CONTROL
June 27, 2005
Provid Pharmaceuticals of North Brunswick, N.J., has entered into a collaborative research agreement with Immune Control of West Conshohocken, Pa., for the development of lead compounds for diseases with immunological causes. Provid will employ its expertise in structure-based design, peptide mimetics technology, and medicinal chemistry to develop the lead compounds.
BioSpace (http://www.biospace.com/news_story.cfm?StoryID=20380820&full=1)